CONNECT: A Multi-Cohort, Prospective Investigation of the Symani® Surgical System
- Sponsor
- MMI (Medical Microinstruments, Inc.)
- Study ID
- NCT06866197
- Status
- Recruiting
Conditions
- Free Tissue Transfer
- Lymphedema
- Microsurgery
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 100 Years
- Healthy Volunteers
- Not accepted
Interventions
- Symani Surgical System — DEVICEThe Symani Surgical System (Symani) is designed for open microsurgery procedures, featuring articulated and interchangeable instruments.
Study Details
The objective of this clinical study is to evaluate the Symani System's safety and effectiveness for microsurgical anastomosis during free tissue transfer surgery and lymphatic surgery. The primary endpoints are: Effectiveness: Clinical Success, defined as intraoperative anastomosis patency. Safety: Freedom from device-related serious adverse events prior to discharge from the index hospitalization, as adjudicated by a Clinical Events Committee. Participants will receive treatment as standard of care and be asked to: Allow the researchers to access and use their information. If participants are undergoing a therapeutic lymphatic procedure, they will be asked to complete a questionnaire and undergo lymphedema volume assessments as part of the study. If participants are undergoing a prophylactic lymphatic procedure, they will only be asked to undergo limb volume assessments. Participants will be asked to comply with the follow-up visits as outlined in the protocol.
Key Dates
- First listed
- Mar 10, 2025
- Start date
- Jan 20, 2026
- Status verified
- Mar 2026
- Primary completion
- Jan 20, 2028
- Completion
- Jan 20, 2029
Study Design
- Enrollment
- 180 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- OTHER
Arms
- Experimental: Free Tissue Transfer, Therapeutic Lymphatic Surgery, Prophylactic Lymphatic Surgery Participants
Primary Outcome Measure
Clinical Success, defined as intraoperative anastomosis patency. [ Time Frame: The duration of the participants' index procedure, from when they enter the OR to when they leave the OR (procedures typically last under 24 hours) ]
Central Contacts
- Clinical Operations8336646276
Related Studies
- Imaging Lymphatic Function in Normal Subjects and in Persons With Lymphatic DisordersEnrolling By Invitation · The University of Texas Health Science Center, Houston · Houston, Texas
- Prospective Screening for Breast Cancer-related LymphedemaRecruiting · Massachusetts General Hospital · Boston, Massachusetts
- A Real-World Registry of Chronic Wounds and UlcersRecruiting · U.S. Wound Registry · The Woodlands, Texas
- Lymphedema Surveillance StudyRecruiting · Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey